M05.67
Rheumatoid arthritis of ankle and foot with involvement of other organs and systems
Clinical Classification Guidelines
Inclusion Terms
- Rheumatoid arthritis of tarsus, metatarsus and phalanges with involvement of other organs and systems
Medical Intelligence & Overview
Rheumatoid arthritis (RA) is a chronic autoimmune condition that primarily affects the joints, causing inflammation, pain, and swelling. When RA involves the ankle and foot, specifically the tarsus, metatarsus, and phalanges, it can significantly impact mobility and daily activities. The ICD-10 code M05.67 describes cases where rheumatoid arthritis affects these joints while also involving other organs and systems within the body. This systemic involvement means that RA is not limited to just the joints but may also affect organs such as the heart, lungs, skin, and eyes, leading to more complex medical management.
Causes & Symptoms
Clinical Causes: Autoimmune response: The immune system mistakenly attacks the synovial membrane of joints. Genetic predisposition: Family history of rheumatoid arthritis increases risk. Environmental factors: Smoking, exposure to certain pollutants, and infections may trigger disease onset. Hormonal influences: Hormonal changes, especially in women, can influence disease development.
Key Symptoms: Persistent joint pain and tenderness, especially in the ankles, feet, toes, and metatarsal areas. Swelling and warmth around the affected joints. Morning stiffness lasting longer than 30 minutes. Deformities or misalignment of toe joints over time. Fatigue and general feelings of malaise. Additional systemic symptoms depending on organ involvement, such as: Shortness of breath if lungs are affected. Chest pain related to pericarditis or lung involvement. Dry eyes or mouth if the eyes or salivary glands are affected. Skin nodules or rashes. Fever and weight loss may also occur in more severe cases.
Diagnostic & Treatment
Diagnosis Path: Medical history assessment focusing on joint symptoms and systemic signs. Physical examination examining joint swelling, deformities, and skin changes. Blood tests: Rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), elevated erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Imaging studies: X-rays or MRI scans of the feet and ankles to identify joint erosion, joint space narrowing, and other structural changes. Assessment of organ involvement through additional tests such as chest X-ray, echocardiogram, or eye examination as needed.
Treatment Protocols: Disease-modifying antirheumatic drugs (DMARDs): Such as methotrexate, to slow disease progression. Biologic agents: Target specific components of the immune system, like TNF inhibitors. Nonsteroidal anti-inflammatory drugs (NSAIDs): To reduce pain and inflammation. Corticosteroids: To manage acute flare-ups and reduce systemic inflammation. Physical therapy: Exercises to maintain joint function and strength. Occupational therapy: Strategies and devices to protect joints and assist daily activities. Assistive devices: Braces, orthotics, or footwear modifications to aid mobility. Lifestyle modifications: Regular low-impact exercise, smoking cessation, and balanced diet. Monitoring: Regular follow-ups to assess disease activity and adjust treatment plans. Management of systemic symptoms: Specific treatments for organ involvement as determined by specialists.
Clinical Advice & FAQs
Billing Guidance
Is M05.67 a billable ICD-10 code?
Yes, M05.67 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M05.67?
Clinical documentation must specify the nature of Rheumatoid arthritis of ankle and foot with involvement of other organs and systems and any associated comorbidities for accurate reporting.
Cite this Clinical Reference